SHANK3 is a gene that assists neurotransmitter connection, synapse formation, and dendrite spine maturation. The autism-associated insertion mutation (InsG) of SHANK3 exon 21 was found in two brothers with clinically identical cases of autism spectrum disorder (ASD), but not in their normally developing brother. This discovery from the University of Texas Southwestern Medical Center suggests that InsG could be a potential cause to certain cases ASD. In a study that recreated InsG in mice, those with the InsG had impaired motor learning and coordination, consistent with the sibling’s symptoms. The group of the InsG mice were then given Tamoxifen while the control group were given a normal diet. The Tamoxifen induced a SHANK3 knock in, causing new segments of SHANK3 to form. As new SHANK3 was synthesized the mice also gained increased motor learning and coordination abilities. The effect of the Tamoxifen on the symptoms of the InsG demonstrated the potential for use as a therapeutic agent.
-
Archives
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- November 2015
- September 2015
- July 2015
- June 2015
- February 2015
- October 2014
- August 2014
- March 2014
- January 2014
- September 2013
- August 2013
- June 2013
- May 2013
- March 2013
- February 2013
- December 2012
- November 2012
- August 2012
- July 2012
- June 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- April 2011
- March 2011
- February 2011
- January 2011
-
Meta